Skip to content
Menu
Ranked #301

NuuVim

NuuVim is a Texas-based DTC telehealth program offering compounded semaglutide and tirzepatide in both injectable and oral forms — oral access is uncommon here — plus limited brand-name Ozempic and Zepbound.

Desk Score 64/100 (C) · Verified August 2026

Visit NuuVimAssume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way.

Is NuuVim legit?

Only what NuuVim publishes and what we could check ourselves — nothing inferred. See the methodology.

Certification
NuuVim publishes a LegitScript certification on its own pages.
Where it ships
The site doesn't say which states it serves.
Last checked
August 2026, against NuuVim's own pages.
Published price
NuuVim publishes a figure for semaglutide and tirzepatide — the qualifiers are in "What does NuuVim cost?" below.
What it sells
Brand-name medication as well as compounded, injectable and oral routes.
Licensing & trust
59/100 on the scored dimension of that name — one of the six in our published methodology.

Checks out as far as the figures go, with one caveat: every price NuuVim publishes carries a condition, so the number on the site is not the monthly bill.

What does NuuVim cost?

Each figure exactly as NuuVim publishes it, with the condition attached to it spelled out.

Semaglutide

$79/mo (all doses, 3-mo plan, new patients only, compounded)

That is a promotional rate: $79 a month is an introductory figure rather than the standing one.

Because that figure carries a condition, it is held out of our "cheapest" rankings and out of the median we compute for semaglutide — only flat month-to-month rates compete there.

Tirzepatide

$133/mo (all doses, 3-mo plan, new patients only, compounded)

That is a promotional rate: $133 a month is an introductory figure rather than the standing one.

Because that figure carries a condition, it is held out of our "cheapest" rankings and out of the median we compute for tirzepatide — only flat month-to-month rates compete there.

All figures as published on NuuVim's own site and read in August 2026. Prices change — confirm before you order.

Semaglutide
$79/mopromo rate
Tirzepatide
$133/mopromo rate
Coverage
Not listed on NuuVim's site (checked August 2026)
Brand-name
Yes
Verification
Prices as published on NuuVim's site — verified august 2026. Each figure's full condition is in “What does NuuVim cost?” below.

Weigh NuuVim against the full ranked field on the best semaglutide providers ranking, or line it up against its closest alternatives. Or go one-on-one: NuuVim vs CoreAge Rx.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency84/100
State access24/100
Molecule range90/100
Onboarding speed60/100
Support responsiveness58/100
Licensing & trust59/100

What we like

  • Low compounded entry pricing — semaglutide from $79/mo, tirzepatide from $133/mo, flat all-dose pricing
  • Both injectable and oral compounded options for semaglutide and tirzepatide (oral access is uncommon)
  • LegitScript Certified and HIPAA-compliant
  • Two named compounding pharmacy partners (Hallandale Pharmacy and Pharmacy Hub), both vetted in our directory
  • Operating legal entity disclosed: NuuVim LLC, Texas governing law

Where points come off

  • There is no month-to-month plan: every rate is billed as one three-month payment
  • The advertised $79 and $133 are introductory rates for customers new to GLP-1s; on renewal they become $133 and $199.67
  • The site's own llms.txt advertises pricing, FAQ and terms files that all 404
  • No state count is published

The bottom line — C

Best for: Low-cost compounded GLP-1s (injection or oral), flat all-dose pricing.

NuuVim ranks #301 of 542 providers scored — see #1, CoreAge Rx here.

Related reviews

Everyone else here (24)

Pricing and verification reflect NuuVim's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on NuuVim's site. Not medical advice; see our disclosure.

← Back to the ranking